Information Journal Paper
APA:
Copy. (2017). Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non– ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS. INTERNATIONAL JOURNAL OF CARDIOLOGY, 232(-), 264-270. SID. https://sid.ir/paper/690670/en
Vancouver:
Copy. Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non– ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS. INTERNATIONAL JOURNAL OF CARDIOLOGY[Internet]. 2017;232(-):264-270. Available from: https://sid.ir/paper/690670/en
IEEE:
Copy, “Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non– ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS,” INTERNATIONAL JOURNAL OF CARDIOLOGY, vol. 232, no. -, pp. 264–270, 2017, [Online]. Available: https://sid.ir/paper/690670/en